Product Reports Resources Pricing Login Book a demo
COMPANY PROFILE

Pictor Labs

Request full access

A digital pathology company using AI to create virtual staining technology that revolutionizes histopathology, speeding up diagnostics and improving patient outcomes

Los Angeles, United StatesFounded 2019Biotech & Life Sciences

About Pictor Labs

Pictor Labs, Inc. is a digital pathology company founded in 2019 as a spin-off from the University of California, Los Angeles (UCLA). The company was established by Dr. Aydogan Ozcan, a UCLA professor of electrical and computer engineering and bioengineering, and Dr. Yair Rivenson, a former postdoctoral member of Dr. Ozcan's research group who now serves as the company's CEO. The foundational technology was developed within the Ozcan Lab at UCLA and subsequently licensed by Pictor Labs. Rivenson's background includes a Ph.D. in Optics/Optical Sciences, with research focused on computational imaging, which directly informs the company's core technology.

The firm operates in the digital pathology and health-tech markets, providing an AI-powered virtual staining platform. Its business model centers on offering this software-based solution to biopharma companies, contract research organizations (CROs), research institutions, and clinical labs. Pictor Labs' technology addresses significant challenges in traditional histopathology, which relies on time-consuming, chemical-based staining processes that have remained largely unchanged for decades. The company's platform ingests high-resolution images of unstained tissue samples and uses proprietary deep learning algorithms to generate a limitless number of virtually stained images. These digital stains, including replicas of standard H&E and specialized IHC biomarker stains, are designed to be indistinguishable from their chemically prepared counterparts and are delivered in minutes.

This approach offers several key benefits. It eliminates the need for chemical reagents, some of which are carcinogenic, making the process safer and more environmentally sustainable. It also preserves the single, precious tissue specimen, allowing for repeated biomarker testing without requiring multiple samples, which is particularly valuable when tissue is limited. For its clients in research and pharma, this accelerates workflows, enables more comprehensive tissue analysis, and supports drug discovery and development. The company has established partnerships with leaders in the field, including Hamamatsu Photonics and PathPresenter, to advance the adoption of its technology. Since its inception, Pictor Labs has raised a total of $48.8 million over four funding rounds, including a $30 million Series B round led by Insight Partners with participation from M Ventures and a strategic investment from LabCorp.

Source: Dealroom company data

At a glance

Status
Operational
Founded
2019
Headquarters
Los Angeles, United States
Employees
43
Open positions
None listed
Dealroom signal
88.5/100
Industry
Health
Sub-industry
BioTechnology
Sector
Biotech & Life Sciences, Biotechnology, Core AI, Biotech and Pharma, AI for medical imaging, AI Applications, DT and LS, science-based
Technology
Artificial Intelligence, Machine Learning
Business model
Manufacturing
Client focus
B2B

Funding history

3 recorded events

Company financing events and reported valuations.

Deal typeDateAmountValuationInvestorsSource
SERIES B✓Equity / VC Sep 2024 $30M $120M M Ventures · Insight Partners ↗
SERIES A✓Equity / VC May 2022 $15M $61M Koç Holding · M Ventures ↗
Showing the latest 2 of 3 recorded eventsBook a demo for the full funding history →

Growth signals

Pictor Labs website traffic

Latest recorded traffic for Pictor Labs is 1.3K monthly website visits, down 7.1% over the last three months. Pictor Labs's team grew 22.9% over the past year.

Latest monthly visits1.3K 3-month web change-7.1% 1-year team growth+22.9%
Summary metrics are public; monthly history is available with a demoCompare with peers →

Similar companies

Closest operating peers by Dealroom taxonomy

Company identity and context are open; selected comparison metrics preview what is available on the platform.

Showing 8 of the closest matchesCompare every metric →

Investments and acquisitions

Capital deployed

Recent portfolio relationships for companies that also act as investors or acquirers.

Pictor Labs in the Los Angeles ecosystem

Live from Dealroom

The Pictor Labs office with the hot startups, most funded companies and investors around it. Hover or tap a pin.

Loading the map…

Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →

Investors

5 investors on the cap table

From Dealroom's funding and investor records, grouped by the round each investor first entered.

Series A3 investors entered at this stage

Other known investors2 additional known investors

Team profiled 8 named & role-tagged
Founders Hidden — book a demo/100 quality score
Key operators 3 quality Hidden — book a demo/100
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Global footprint

Workforce and web traffic by country
Workforce by country
5 countries with
team presence
🇺🇸 United States88.6%
🇮🇳 India2.9%
🇳🇱 Netherlands2.9%
🇬🇧 United Kingdom2.9%
🇮🇱 Israel2.9%
5 countries shown

Market sentiment

Posts on X, past 7 days

An AI-synthesised read of the highest-engagement posts about Pictor Labs on X, ranked by likes and reposts, corporate channels excluded.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Pictor Labs’s full profile on Dealroom

Request a free trial to see the complete deal history, financials, people graph and growth signals.

Takes under a minute. Already use Dealroom? Log in.